Purpose
The purpose of this assignment is to enhance the student’s clinical reasoning, confidence and learning of multiple pharmacological agents through facilitated discussion.
Description
In Week 6, you will create a PowerPoint Grand Rounds presentation on the topic assigned to you by the faculty member. In Week 7, you will lead a discussion based on your presentation as well as interact with peers in discussions related to their Grand Rounds presentations.
Course Outcomes
Through this assignment, the student will demonstrate the ability to:
1. Describe the most commonly prescribed drugs use in primary care for the chose condition.
2. Utilize clinical guidelines, research articles or other materials to support your findings.
3. Identify any practice barriers, issues, or problems (including cultural diversity and healthcare literacy).
4. Discuss best practices for optimal outcomes.
Due Dates: Week 6: Grand Rounds PowerPoint Presentation due by Sunday 11:59 p.m. MT at the end of Week 6.
Week 7: Presentation must be uploaded to Week 7 discussion by Sunday 11:59 p.m. MT at the end of Week 6. Three responses to a peer’s presentations are due by Thursday 11:59 p.m. MT of Week 7, answers five questions in three different presentations (total of 15) and all follow-up posts to your presentation due by Sunday at 11:59 p.m. MT at the end of Week 7.
Total Points Possible: Week 6 PowerPoint- 75 points
Week 7 Discussion- 75 points
In Week 6, create a PowerPoint presentation related to a common condition in primary care. Your professor will assign you the condition that you are to present.
In a PowerPoint presentation of 15 slides or less, describe the most commonly prescribed drugs for your assigned condition. Provide evidence by sharing clinical guidelines, research articles, or other scholarly materials to support your findings. You will identify barriers to practice or additional issues related to the condition and the use of pharmacologic treatment, including potential issues related to cultural diversity and healthcare literacy.
Read the following article and incorporate evidence from it as a part of your presentation: Dreischulte, T., & Guthrie, B. (2012). High-risk prescribing and monitoring in primary care: how common is it, and how can it be improved?. Therapeutic advances in drug safety, 3(4), 175-184. The article can be found at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110851/
Finally, you will describe the expected outcomes for medication management, including expectations for follow up care. Citations should be provided at the bottom of slides, and a full reference list should be included in APA format on the final slide. You will create five (5) multiple choice or true-false questions created from your presentation content. Provide the answers to the questions you have created. The PowerPoint presentation and questions are due by Sunday 11:59 p.m. MT at the end of Week 6.
In Week 7, you will post the PowerPoint presentation you have created to the discussion area, but first remove the answers to the questions you have created. Please post the presentation including five (5) questions to the discussion area by Sunday 11:59 p.m. MT at the end of Week 6 to facilitate a robust discussion.
Participating in the Discussion: You will be required to respond to at least three other students, who have no responses to their posting.** In your post, you will discuss a drug that could be prescribed for the condition DIFFERENT than those presented. Come up with a different treatment plan from the Walmart or Target $4 RX list, and offer reasons for the change or if the drug is not on the list, why? Use references to support your responses. You should also answer the presenter’s five questions.
Three responses to a peer’s presentations are due by Thursday 11:59 p.m. MT of Week 7 so that the presenting student can interact with you.
**If all students have a response, then choose the student with the least responses to their posting.
Leading the Discussion: You must respond to any student who posts to you by THURSDAY regarding your case with a substantial response, either answering their questions or noting their response and acting as leader. You also must respond to any faculty responses to your initial posting if posted by THURSDAY. Use references to support your responses. All FINAL responses to your initial posts must be completed by Sunday, 11:59 p.m. MT.
Grand Rounds PowerPoint Week 6
| Category | Points | % | Description |
| Case Study Presentation | 15 | Presents a case using a fictional patient who presents to clinic with assigned medical condition. Provides detailed description of patient, including signs and symptoms of condition | |
| Medication Management | 20 | Describes, in detail, the most commonly prescribed drugs for condition, including trade and generic names, typical dosages, mechanism of action, adverse effects, and major contraindications and interactions. Describes alternate therapies. | |
| Evidence Based Support | 10 | Provides evidence from clinical guidelines, research-based articles, or other appropriate provider-level resources. Includes evidence from Dreischulte & Guthrie (2012) article. | |
| Barriers to Practice | 5 | Describes potential barriers, issues, or problems related to disease process and prescribing, including potential issues related to cultural or socioeconomic diversity and healthcare literacy | |
| Identifying Outcomes | 5 | Describe optimal outcomes after treatment with suggested medication | |
| Test Questions | 15 | Includes five (5) knowledge-based questions related to presentation materials | |
| Formatting | 5 | Slides are clear and easy to read. No more than 15 slides (excluding test question and reference slides) are submitted. References use APA format. | |
| Total | 75 | 100 | A quality assignment will meet or exceed all of the above requirements. |
Grading Rubric PowerPoint Presentation- Week 6
| Criterion | Exceptional
Outstanding or highest level of performance |
Exceeds
Very good or high level of performance |
Meets
Satisfactory level of performance |
Needs Improvement
Poor or failing level of performance |
Developing
Unsatisfactory level of performance |
| Content
Possible Points = 70 |
|||||
| Case Study Presentation | 15 Points | 13 Points | 12 Points | 6 Points | 0 Points |
| Presents a case using a fictional patient who presents to clinic with assigned medical condition. Provides detailed description of patient, including signs and symptoms of condition. | Presents a case using a fictional patient who presents to clinic with assigned medical condition. Provides detailed description of patient, but omits some signs and symptoms of condition. | Presents a case using a fictional patient who presents to clinic with assigned medical condition. Provides vague description of patient and omits some signs and symptoms of condition. | Presents a case using a fictional patient who presents to clinic with assigned medical condition, but does not provide description of patient, including signs and symptoms of condition. | Does not present a case study. | |
| Medication Management | 20 Points | 18 Points | 16 Points | 8 Points | 0 Points |
| Describes, in detail, the first line prescribed drugs for condition, including trade and generic names, typical dosages, mechanism of action, adverse effects, and major contraindications and interactions. Describes alternate therapies. | Generally describes the first line prescribed drugs for condition, omitting one of the following: trade and generic names, typical dosages, mechanism of action, adverse effects, and major contraindications and interactions, and alternate therapies. | Generally describes the first line prescribed drugs for condition, omitting 2-3 of the following: trade and generic names, typical dosages, mechanism of action, adverse effects, and major contraindications and interactions, and alternate therapies. | Generally describes the first line prescribed drugs for condition, or incorrectly identifies first line drug, omitting 4 or more of the following: trade and generic names, typical dosages, mechanism of action, adverse effects, and major contraindications and interactions, and alternate therapies. | Does not describe medications for condition. | |
| Evidence-Based Support | 10 Points | 9 Points | 8 Points | 4 Points | 0 Points |
| Provides evidence from clinical guidelines, research-based articles, or other appropriate provider-level resources. Includes evidence from Dreischulte & Guthrie (2012) article. | Provides evidence from clinical guidelines, research-based articles, or other appropriate provider-level resources. Does not include evidence from Dreischulte & Guthrie (2012) article. | Provides evidence from sources other than clinical guidelines, research-based articles, or other appropriate provider-level resources. Includes evidence from Dreischulte & Guthrie (2012) article. | Provides evidence from sources other than clinical guidelines, research-based articles, or other appropriate provider-level resources. Does not include evidence from Dreischulte & Guthrie (2012) article. | Does not provide evidence to support. | |
| Barriers to Practice | 5 Points | 4 Points | 3 Points | 1 Point | 0 Points |
| Describes potential barriers, issues, or problems related to disease process and prescribing, including potential issues related to cultural or socioeconomic diversity and healthcare literacy. | Describes potential barriers, issues, or problems related to disease process and prescribing, but omits potential issues related to either cultural, socioeconomic diversity, or healthcare literacy. | Describes potential barriers, issues, or problems related to disease process and prescribing, but omits potential issues related to two of the following: cultural, socioeconomic diversity, or healthcare literacy. | Describes potential barriers, issues, or problems related to disease process and prescribing, but omits potential issues related to cultural, socioeconomic diversity, AND healthcare literacy. | Does not describe potential barriers. |
Delivering a high-quality product at a reasonable price is not enough anymore.
That’s why we have developed 5 beneficial guarantees that will make your experience with our service enjoyable, easy, and safe.
You have to be 100% sure of the quality of your product to give a money-back guarantee. This describes us perfectly. Make sure that this guarantee is totally transparent.
Read moreEach paper is composed from scratch, according to your instructions. It is then checked by our plagiarism-detection software. There is no gap where plagiarism could squeeze in.
Read moreThanks to our free revisions, there is no way for you to be unsatisfied. We will work on your paper until you are completely happy with the result.
Read moreYour email is safe, as we store it according to international data protection rules. Your bank details are secure, as we use only reliable payment systems.
Read moreBy sending us your money, you buy the service we provide. Check out our terms and conditions if you prefer business talks to be laid out in official language.
Read more
Recent Comments